REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,712,748 | +228.8% | 26,606 | -15.0% | 0.01% | +350.0% |
| Q4 2021 | $825,000 | -68.2% | 31,294 | +21.4% | 0.00% | -75.0% |
| Q3 2021 | $2,594,000 | -38.9% | 25,784 | -14.0% | 0.01% | -42.9% |
| Q2 2021 | $4,244,000 | +114.0% | 29,988 | +50.8% | 0.01% | +100.0% |
| Q1 2021 | $1,983,000 | -15.2% | 19,890 | +5.2% | 0.01% | -12.5% |
| Q4 2020 | $2,338,000 | +10.9% | 18,915 | -12.6% | 0.01% | 0.0% |
| Q3 2020 | $2,109,000 | -18.7% | 21,647 | +30.2% | 0.01% | -27.3% |
| Q2 2020 | $2,594,000 | +24.2% | 16,625 | +14.9% | 0.01% | +10.0% |
| Q1 2020 | $2,089,000 | -29.4% | 14,474 | 0.0% | 0.01% | -9.1% |
| Q4 2019 | $2,959,000 | – | 14,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
| Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
| First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
| Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
| MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
| Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
| Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
| Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
| KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
| Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |